METHOD OF TREATMENT OF PSORIASIS

FIELD: medicine; dermatology. ^ SUBSTANCE: photo-chemotherapy course is taken four times a week during four weeks. Prolactin and thryrotrophic hormone is found in blood. Parlodel is prescribed at specific factors in parallel with photo-chemotherapy. In case factors of prolactin grow higher than 720...

Full description

Saved in:
Bibliographic Details
Main Authors GOL'TSEVA TAMARA ALEKSANDROVNA, GROMOV KONSTANTIN GEORGIEVICH, URBANSKIJ ALEKSANDR SERGEEVICH, CHASOVNIKOV KONSTANTIN VIKTOROVICH, MEDVEDEVA NATAL'JA LEONIDOVNA, CHEKUSHIN RAMIL' KHUSANOVICH
Format Patent
LanguageEnglish
Russian
Published 10.07.2007
Subjects
DIAGNOSIS
ELECTROTHERAPY
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
RADIATION THERAPY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SURGERY
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:FIELD: medicine; dermatology. ^ SUBSTANCE: photo-chemotherapy course is taken four times a week during four weeks. Prolactin and thryrotrophic hormone is found in blood. Parlodel is prescribed at specific factors in parallel with photo-chemotherapy. In case factors of prolactin grow higher than 720 mME/l and thryrotrophic hormone gets higher than 4,2 mcME/ml, parlodel is introduced before meals in amount of 1,25 mg twice a day in mornings and evenings during 30 days. Then it is introduced during 2 months in amount of 0,625 mg mornings and evenings. Then parlodel is introduced during 3 months in amount of 0,625 mg twice a day in the evening and in the morning. In 6 months levels of prolactin and thryrotrophic hormone are checked again. If prolactin factors excess 65-720 mME/l and thryrotrophic hormone factors excess 0,4-4,2 mcME/l, introduction of prolactin is canceled. If prolactin factor is higher than 720 mME/l and thryrotrophic hormone factor is higher than 4,2 mcME/l, course is repeated. ^ EFFECT: improved efficiency of treatment; prolonged remission periods; reduced side effects. ^ 3 att
Bibliography:Application Number: RU20050135314